A detailed history of Investors Asset Management Of Georgia Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Investors Asset Management Of Georgia Inc holds 18,028 shares of ABBV stock, worth $2.95 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
18,028
Previous 18,198 0.93%
Holding current value
$2.95 Million
Previous $2.82 Million 16.38%
% of portfolio
1.57%
Previous 1.44%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $27,169 - $30,957
-170 Reduced 0.93%
18,028 $3.28 Million
Q4 2023

Jan 31, 2024

SELL
$137.6 - $154.97 $19,264 - $21,695
-140 Reduced 0.76%
18,198 $2.82 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $34,733 - $40,209
260 Added 1.44%
18,338 $2.73 Million
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $196,114 - $244,052
-1,480 Reduced 7.57%
18,078 $2.44 Million
Q1 2023

May 01, 2023

BUY
$144.61 - $166.54 $10,845 - $12,490
75 Added 0.38%
19,558 $3.12 Million
Q4 2022

Feb 02, 2023

SELL
$138.31 - $165.87 $32,226 - $38,647
-233 Reduced 1.18%
19,483 $3.15 Million
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $67,776 - $77,734
505 Added 2.63%
19,716 $2.65 Million
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $48,855 - $62,110
-355 Reduced 1.81%
19,211 $2.94 Million
Q1 2022

Apr 20, 2022

BUY
$131.98 - $163.75 $9,898 - $12,281
75 Added 0.38%
19,566 $3.17 Million
Q4 2021

Feb 03, 2022

SELL
$107.43 - $135.93 $8,594 - $10,874
-80 Reduced 0.41%
19,491 $2.64 Million
Q3 2021

Oct 14, 2021

BUY
$106.4 - $120.78 $206,948 - $234,917
1,945 Added 11.03%
19,571 $2.11 Million
Q2 2021

Jul 09, 2021

SELL
$105.21 - $117.21 $5,260 - $5,860
-50 Reduced 0.28%
17,626 $1.99 Million
Q1 2021

Apr 21, 2021

BUY
$102.3 - $112.62 $37,339 - $41,106
365 Added 2.11%
17,676 $1.91 Million
Q4 2020

Jan 28, 2021

SELL
$80.49 - $108.67 $38,232 - $51,618
-475 Reduced 2.67%
17,311 $1.86 Million
Q3 2020

Oct 14, 2020

BUY
$85.91 - $100.83 $4,295 - $5,041
50 Added 0.28%
17,786 $1.56 Million
Q2 2020

Jul 31, 2020

SELL
$73.37 - $98.18 $22,964 - $30,730
-313 Reduced 1.73%
17,736 $1.74 Million
Q1 2020

Apr 21, 2020

BUY
$64.5 - $97.79 $67,725 - $102,679
1,050 Added 6.18%
18,049 $1.38 Million
Q4 2019

Jan 15, 2020

SELL
$72.13 - $90.25 $32,458 - $40,612
-450 Reduced 2.58%
16,999 $1.51 Million
Q3 2019

Oct 17, 2019

BUY
$62.98 - $75.72 $9,447 - $11,358
150 Added 0.87%
17,449 $1.32 Million
Q2 2019

Jul 10, 2019

BUY
$65.7 - $83.98 $448,271 - $572,995
6,823 Added 65.13%
17,299 $1.26 Million
Q1 2019

Apr 17, 2019

BUY
$77.14 - $90.79 $4,628 - $5,447
60 Added 0.58%
10,476 $844,000
Q4 2018

Jan 22, 2019

SELL
$77.85 - $96.01 $24,522 - $30,243
-315 Reduced 2.94%
10,416 $960,000
Q3 2018

Oct 25, 2018

BUY
$88.91 - $98.84 $8,891 - $9,884
100 Added 0.94%
10,731 $1.02 Million
Q2 2018

Jul 27, 2018

BUY
$89.78 - $106.23 $50,635 - $59,913
564 Added 5.6%
10,631 $985,000
Q1 2018

Apr 11, 2018

SELL
$92.01 - $123.21 $23,002 - $30,802
-250 Reduced 2.42%
10,067 $953,000
Q4 2017

Jan 11, 2018

SELL
$89.56 - $98.21 $98,784 - $108,325
-1,103 Reduced 9.66%
10,317 $998,000
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $797,686 - $1.02 Million
11,420
11,420 $1.02 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Investors Asset Management Of Georgia Inc Portfolio

Follow Investors Asset Management Of Georgia Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Asset Management Of Georgia Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investors Asset Management Of Georgia Inc with notifications on news.